REBECCA CHRISTENSEN: Open Payments
NPI 1376239194 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,465 in 133 payments from 13 companies in 2025. Trend: 2023 $958 · 2024 $1,715 · 2025 $2,465
Food & beverage: $2,244Education: $221
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $477 |
| Teva Pharmaceuticals USA, Inc. | 19 | $443 |
| ABBVIE INC. | 30 | $390 |
| Axsome Therapeutics, Inc. | 13 | $292 |
| Alkermes, Inc. | 19 | $232 |
| Neurocrine BioSciences, Inc. | 9 | $180 |
| E.R. Squibb & Sons, L.L.C. | 10 | $138 |
| TG Therapeutics, Inc. | 1 | $128 |
| Supernus Pharmaceuticals, Inc. | 4 | $79 |
| Lundbeck LLC | 2 | $41 |
Products named: CAPLYTA, VRAYLAR, Auvelity, ARISTADA, INGREZZA, COBENFY, UZEDY, BRIUMVI.
Industry payments across SD — which companies pay providers there.
